about
Application and Dosimetric Requirements for Gallium-68-labeled Somatostatin Analogues in Targeted Radionuclide Therapy for Gastroenteropancreatic Neuroendocrine TumorsAn Alternate, Egg-Free Radiolabeled Meal Formulation for Gastric-Emptying Scintigraphy.Targeting the human malaria parasite Plasmodium falciparum: in vitro identification of a new antiplasmodial hit in 4-phenoxy-2-trichloromethylquinazoline series.Therapeutic benefit of a combined strategy using erythropoietin and endothelial progenitor cells after transient focal cerebral ischemia in rats.Long-Term Recovery After Endothelial Colony-Forming Cells or Human Umbilical Cord Blood Cells Administration in a Rat Model of Neonatal Hypoxic-Ischemic Encephalopathy.Erythropoietin Pretreatment of Transplanted Endothelial Colony-Forming Cells Enhances Recovery in a Cerebral Ischemia Model by Increasing Their Homing Ability: A SPECT/CT Study.The Evolving Role of Succinate in Tumor Metabolism: An 18F-FDG-Based Study.Safe Cytotoxic Drug Preparation Using Closed-system Transfer Device: Technical and Practical Evaluation of a New Device (Vialshield/Texium) Comparatively to a Reference One (Phaseal).Single photon emission computed tomography imaging of cerebral blood flow, blood-brain barrier disruption, and apoptosis time course after focal cerebral ischemia in rats.Soluble CD146 boosts therapeutic effect of endothelial progenitors through proteolytic processing of short CD146 isoform.ARA290, a Specific Agonist of Erythropoietin/CD131 Heteroreceptor, Improves Circulating Endothelial Progenitors' Angiogenic Potential and Homing Ability.Prospective comparison of (68)Ga-DOTATATE and (18)F-FDOPA PET/CT in patients with various pheochromocytomas and paragangliomas with emphasis on sporadic cases.Prospective evaluation of Ga-DOTATATE PET/CT in limited disease neuroendocrine tumours and/or elevated serum neuroendocrine biomarkersSelf-assembling supramolecular dendrimer nanosystem for PET imaging of tumorsEarly prediction of revascularisation by angiomotin-targeting positron emission tomographyThromboxane-prostaglandin receptor antagonist, terutroban, prevents neurovascular events after subarachnoid haemorrhage: a nanoSPECT study in ratsHave you looked for "stranger things" in your automated PET dose dispensing system? A process and operators qualification schemeFemale AhR Knockout Mice Develop a Minor Renal Insufficiency in an Adenine-Diet Model of Chronic Kidney DiseaseA self-assembling amphiphilic dendrimer nanotracer for SPECT imagingA Comprehensive Review of Non-Covalent Radiofluorination Approaches Using Aluminum [18F]fluoride: Will [18F]AlF Replace 68Ga for Metal Chelate Labeling?ESICM LIVES 2016: part one: Milan, Italy. 1-5 October 2016Uremic Toxic Blood-Brain Barrier Disruption Mediated by AhR Activation Leads to Cognitive Impairment during Experimental Renal Dysfunction
P50
Q26783272-71E87313-505D-4CAB-A2BB-A8E7C7CAE986Q38844325-E76E726E-A28C-42D5-BB7D-0EC684D220E8Q39510158-7EAFED99-2368-4971-A702-F11A7E251DA1Q44045737-6BDB30EB-552E-4267-B828-CB0CFB6088E6Q48033090-0DD510A0-B379-4301-89CB-E9B4CF454448Q48446597-960008D7-1B6F-4427-9ECD-F605381CA684Q50942203-AA432958-1B23-496E-9B98-DA706DE013C7Q51284983-D563988C-5C56-48F2-B8F8-E97EAD97107EQ52144823-4D819575-40CC-4B60-8AA4-0BE6CE18F21AQ52870031-1D28A320-29F7-4611-AAEA-B9AF881D7764Q52983005-E89FBBFC-4FE3-4C78-9275-724CF204A1D4Q52987280-C3E490A4-E55C-416F-A1F0-A9BD22098248Q57100896-4F6D13A1-A827-4257-8E93-A7706F4874C9Q57805470-338A8F64-B80F-4F62-ABFD-752612E6F625Q59138135-FC8DA7AC-4BC8-46B0-BE25-590E1461495CQ64236955-2EEA2973-B523-4417-A208-C4D04A3722A4Q90976746-1E63388F-D44B-476B-95CD-55C45D288067Q91667606-DF52B974-EB46-43CA-80C7-88B16E0DD065Q91749171-D0F578F0-2711-4463-93B4-323488F89703Q92503500-8F8345B5-1D11-4F63-97FE-B9E6FC55310AQ93951547-F4EED419-B7F8-427C-A6C2-02024585A634Q96302372-2F5CF69C-9DBD-4C13-B4CD-274A2F227160
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Philippe Garrigue
@ast
Philippe Garrigue
@en
Philippe Garrigue
@es
Philippe Garrigue
@nl
Philippe Garrigue
@sl
type
label
Philippe Garrigue
@ast
Philippe Garrigue
@en
Philippe Garrigue
@es
Philippe Garrigue
@nl
Philippe Garrigue
@sl
prefLabel
Philippe Garrigue
@ast
Philippe Garrigue
@en
Philippe Garrigue
@es
Philippe Garrigue
@nl
Philippe Garrigue
@sl
P106
P31
P496
0000-0002-5712-2055